Glucose-6-phosphate dehydrogenase (G6PD). Response of the human erythrocyte and another cells to the decrease in their activity

Fuente: Redalyc
Guardado en:
Detalles Bibliográficos
Autor principal: Javier Fernando Bonilla
Formato: Artículo científico
Lenguaje:en
Publicado: Universidad del Valle 2007
Materias:
Acceso en línea:
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
_version_ 1876485041712791552
author Javier Fernando Bonilla
author_facet Javier Fernando Bonilla
contents Glucose-6-phosphate dehydrogenase (G6PD). Response of the human erythrocyte and another cells to the decrease in their activity Javier Fernando Bonilla Magda Carolina Sánchez Lilian Chuaire Medicina Glucose Genetics Physiology Erythrocyte Epidemiology Glucose-6-phosphate dehydrogenase is the first enzyme in the pentose phosphate pathway and the main intracellular sourceof reduced nicotidamineadenine nucleotidephosphate (NADPH), involved in diverse physiological processes such as antioxidantdefense, (for instance in the erythrocyte) endothelial growth modulation, erithropoyesis, vascularization and phagocitosis. G6PDHdeficiency is the most common X-chromosome-linked enzymopathy in human beings. Although it is present in any type cell, itsabsolute deficiency is incompatible with life. According to WHO, 400 million people are affected by G6PD deficiency in the worldbut in Colombia, the severe form prevalence is about 3% to 7%. There are no data related to slight and moderate alterations, thatalso have clinical effects. This paper reviews some G6PD biomolecular aspects, its classification according to activity andelectrophoretic mobility, as well as some main clinical aspects related to its activity alteration 2007 artículo científico 0120-8322 https://www.redalyc.org/articulo.oa?id=28338112 en http://www.redalyc.org/revista.oa?id=283 Colombia Médica application/pdf Universidad del Valle Colombia Médica (Colombia) Num.1 Vol.38
format Artículo científico
id redalyc_28338112
institution Redalyc
language en
publishDate 2007
publisher Universidad del Valle
spellingShingle Glucose-6-phosphate dehydrogenase (G6PD). Response of the human erythrocyte and another cells to the decrease in their activity
Javier Fernando Bonilla
Medicina
Glucose
Genetics
Physiology
Erythrocyte
Epidemiology
Glucose-6-phosphate dehydrogenase (G6PD). Response of the human erythrocyte and another cells to the decrease in their activity Javier Fernando Bonilla Magda Carolina Sánchez Lilian Chuaire Medicina Glucose Genetics Physiology Erythrocyte Epidemiology Glucose-6-phosphate dehydrogenase is the first enzyme in the pentose phosphate pathway and the main intracellular sourceof reduced nicotidamineadenine nucleotidephosphate (NADPH), involved in diverse physiological processes such as antioxidantdefense, (for instance in the erythrocyte) endothelial growth modulation, erithropoyesis, vascularization and phagocitosis. G6PDHdeficiency is the most common X-chromosome-linked enzymopathy in human beings. Although it is present in any type cell, itsabsolute deficiency is incompatible with life. According to WHO, 400 million people are affected by G6PD deficiency in the worldbut in Colombia, the severe form prevalence is about 3% to 7%. There are no data related to slight and moderate alterations, thatalso have clinical effects. This paper reviews some G6PD biomolecular aspects, its classification according to activity andelectrophoretic mobility, as well as some main clinical aspects related to its activity alteration 2007 artículo científico 0120-8322 https://www.redalyc.org/articulo.oa?id=28338112 en http://www.redalyc.org/revista.oa?id=283 Colombia Médica application/pdf Universidad del Valle Colombia Médica (Colombia) Num.1 Vol.38
title Glucose-6-phosphate dehydrogenase (G6PD). Response of the human erythrocyte and another cells to the decrease in their activity
topic Medicina
Glucose
Genetics
Physiology
Erythrocyte
Epidemiology
url https://www.redalyc.org/articulo.oa?id=28338112